Navigation Links
DelSite Chairman George DeMott Resigns
Date:12/11/2008

Board Appoints Carlton Turner as Chairman, Robert Schnitzius as Acting President & CEO

IRVING, Texas, Dec 11 /PRNewswire-FirstCall/ -- DelSite, Inc. (OTC Bulletin Board: DSII.OB), a drug delivery technology company, today announced that George DeMott, chairman of the board of directors for the Company, has resigned his position as chairman, effective immediately. Mr. DeMott will continue to serve on the board until his term ends in May 2009.

The board of directors of DelSite, Inc., named Dr. Carlton Turner as chairman. Dr. Turner is retiring from his position as president and CEO as of December 31, 2008. The board has also appointed Robert Schnitzius, the company's chief financial officer, as acting president and CEO, effective January 1, 2009.

Mr. DeMott has been the board's chairman since 1995. He has overseen the transition of Carrington Laboratories, Inc. from a wound care manufacturing company with basic R&D into a vaccine and drug delivery company.

DelSite Biotechnologies, Inc (DSBI) was established as a wholly-owned subsidiary of Carrington in 2001. DSBI's business plan was to develop Carrington's proprietary vaccine and drug delivery technology. Under Mr. DeMott's leadership and based on DSBI advancements, Carrington exited the wound care business and changed its name from Carrington Laboratories to DelSite, Inc. in June of this year.

DelSite continues to transition itself into a more traditional biotech company focused on delivery platforms for vaccines and drugs. Core technology is a naturally occurring linear, negatively charged carbohydrate polymer with the ability to stabilize proteins and peptides.

Mr. DeMott said, "DelSite has completed the Phase I safety of our nasal powder delivery platform GelVac(TM) and has also filed an IND for a Phase I effectiveness and safety study of a GelVac(TM) formulated influenza va
'/>"/>

SOURCE DelSite, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Carringtons DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office
2. Carringtons DelSite Presentation at Rodman & Renshaw Conference to be Webcast Live on November 7th
3. Carrington Subsidiary DelSite to Present at Investor Conference
4. Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland
5. Statement of DNC Chairman Howard Dean on World AIDS Day
6. Cardiome Discloses Chairman And CEOs Involuntary Share Sale
7. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
8. MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
9. AMERIGROUP Chairman and CEO Urges Action to Improve Nations Premature Birth Report Card
10. As Chairman Baucus Outlines Vision for Healthcare Reform, NACDS Emphasizes Pharmacy's Essential Role in Any Successful Overhaul
11. The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and often ... 51st Annual Meeting of the American Society of ... diagnostic methods for patients suffering from acute promyelocytic ... and myelofibrosis that are based on a better ...
(Date:12/5/2009)... with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) ... birthday without ever tying the knot, since research has shown ... And, um, isn,t there something wrong with those who go ... study looking at psychological measures shows that never-married people aged ...
(Date:12/5/2009)... an innovative new international private medical insurance plan which follows the ... customers the flexibility to add or remove a wide range of ... to tailor their benefits to complement those already offered in their ... ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... study finds , , WEDNESDAY, Jan. 16 (HealthDay News) -- ... of breast cancer in postmenopausal women, it really raises ... breast cancer. , The authors of a new study, ... Cancer Epidemiology, Biomarkers & Prevention , also found that ...
... this release there are hypnotic suggestions about why you should cover ... able to pick out the suggestions? Or would they work without ... in the news, you came to the realization that you absolutely, ... unless you read on , In his fifth and new self-published ...
... Solution for Health Portal ... ... http://www.healthcare.com ), the leading healthcare provider directory and,online health destination, today ... a leading creator and,syndicator of interactive health content to healthcare companies,government ...
... Dr. Bart Harmon, MD,MPH, a national leader ... joined Harris Corporation (NYSE: HRS ) ... new Healthcare Solutions business. Harris Healthcare,Solutions is ... healthcare clients by leveraging the company,s leadership ...
... 16 Chem Rx Corporation,(OTC Bulletin Board: PMQC, PMQCU, ... the appointment of three,new directors to its board of ... M. Gozia, Robert R. Hinckley and Andrew R. Jones., ... 2007, Interim Chief,Executive Officer of ForeFront Holdings, Inc., a ...
... directly linked to several diseases such as hypertension and type ... adipose tissues and may form a biochemical link between obesity ... insulin inhibits resistin mRNA level in 3T3-L1, which does not ... play a role in insulin resistance? Is insulin the major ...
Other Medicine News:Health News:HRT Raises Risk of Lobular Breast Cancer 2Health News:HRT Raises Risk of Lobular Breast Cancer 3Health News:Hypnotist ready to kick cigarette butt 2Health News:HealthCare.com & MediResource Partner to Distribute and License Health Content, Directory and Tools 2Health News:HealthCare.com & MediResource Partner to Distribute and License Health Content, Directory and Tools 3Health News:Dr. Bart Harmon Named Chief Medical Officer for Harris Corporation's Healthcare Solutions Business 2Health News:Dr. Bart Harmon Named Chief Medical Officer for Harris Corporation's Healthcare Solutions Business 3Health News:Chem Rx Announces the Appointment of Three New Directors 2Health News:Chem Rx Announces the Appointment of Three New Directors 3Health News:Chem Rx Announces the Appointment of Three New Directors 4
(Date:12/4/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today ... the company,s Phase II-b, dose escalation, clinical trial in ... injury (TBI). Oxycyte is the Company,s perfluorocarbon (PFC) therapeutic ... in improving the outcome of patients with severe TBI. ...
(Date:12/4/2009)... 4 PharmAthene, Inc. (NYSE Amex: PIP ), ... chemical threats, announced today the presentation of new data ... lyophilized recombinant Protective Antigen (rPA) based anthrax vaccine is ... temperatures up to and including 55 degrees C. ...
(Date:12/4/2009)... stored in tin cans and car trunks ,, ... urged the Senate to defeat the Dorgan Importation plan encompassed ... importation amendment is poised to open our borders, allowing our ... to be endangered. We could soon be getting drugs ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting 4504 1Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting 4504 2Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting 4504 3ChemGenexs omacetaxine may provide first viable treatment option for highly resistant form of CML 47509 1ChemGenexs omacetaxine may provide first viable treatment option for highly resistant form of CML 47509 2Dont mistake an athlete for a toxic jock 47507 1Dont mistake an athlete for a toxic jock 47507 2
... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
Extra-large 3.2mm channel allows excellent suction with EndoTherapy devices in place....
... bronchofiberscope yet. The BF-3C40's distal end measures ... the previous model. It also offers better ... to the use of extra-fine optical fibers ... size by 70 percent. Images are clearer, ...
Facilitates one-lung ventilation when using dual lumen endobronchial tubes....
Medicine Products: